Investor Relations

Trading On:

TSX: VPH  |  OTCQB: VPHIF  |  FSE: VP2

Valeo Pharma (TSX:VPH) is a Canadian pharmaceutical company focused on the following therapeutic areas: Respiratory/Allergy, Ophthalmology, and Specialty Products. Within these areas Valeo now has 10 marketed brands contributing to significant growth for the coming year.

Investor Relations Contact

Frederic Dumais
Director Communications & Investor Relations
[email protected]

Head Office

16667, Hymus Boul.
Kirkland, Qc
H9H 4R9

Analysts

Christopher Pu
Industrial Alliance
1 (587) 590-4144

Scott McAuley
Paradigm Capital
1 (416) 361-9080

Andre Uddin
Research Capital Corporation
1 (416) 860-8675

Stefan Quenneville
Echelon Capital Markets
1 (416) 662-6134